This finding is consistent with the results of the immunocytochemical analysis of the control untreated and EPS-treated HeLa carcinoma cells, demonstrating a marked decrease in the expression of the nuclear proliferation marker Ki67. The gene discussed is MKI67; the disease is carcinoma.